Compare Koninklijke Philips NV (PHG) vs Invesco S&P 500 Momentum ETF (SPMO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Invesco S&P 500 Momentum ETF — how do they compare? Koninklijke Philips NV trades at $24.22 (market cap $23.52B), while Invesco S&P 500 Momentum ETF trades at $151.2 (market cap $23.48B). The key difference: Koninklijke Philips NV and Invesco S&P 500 Momentum ETF are close in size by market cap, and Koninklijke Philips NV pays a 4.17% dividend while Invesco S&P 500 Momentum ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Invesco S&P 500 Momentum ETF for 54 Days on average.
| PHG | SPMO | |
|---|---|---|
Market Cap | $23.52B | $23.48B |
Volume | 1,635,069 | 1,876,152 |
Sector | Health | Broad Market / Factor |
52-Week High | $32.91 | $161.66 |
52-Week Low | $23.81 | $107.84 |
Typical Hold Time | 84 Days | 54 Days |
Enterprise Value | $29.87B | — |
Dividend Yield | 4.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.24, up 0.62% today, amid a bearish technical signal from moving averages. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results pending. Recent financials show a return to profitability in 2025 with net income of $895 million, while cash flow from operations remains positive at $1.17 billion. Key developments include new product launches in healthcare imaging and a $33.7 million ARPA-H award for AI-enabled stroke care.
The outlook is mixed: strong earnings momentum and solid profitability metrics support upside, but technical weakness and a high 'Hold' analyst consensus suggest near-term caution. Risks include competitive pressures and debt levels, though institutional buying activity indicates underlying confidence.
SPMO trades at $151.16, down 1.2% on the day, with technical indicators showing mixed signals—bullish moving averages but neutral oscillators. The ETF recently completed its semi-annual reconstitution, replacing 54 stocks and increasing concentration in momentum-driven sectors like technology and energy. Recent institutional buying by Envestnet Asset Management highlights continued investor interest in the momentum strategy.
The outlook remains balanced; SPMO's historical outperformance versus the S&P 500 supports its strategy, but high concentration and sector-specific risks pose volatility. Investors should weigh the ETF's momentum screen efficacy against potential drawdowns during market shifts. Near-term price action will hinge on broader index trends and post-rebalance performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Invesco S&P 500 Momentum ETF
SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →
